SRX6044155 DNRNMT_I_R4_3PTAG SRP201120 PRJNA547607 RNA-Seq was performed by Lexogen, GmbH, on cytoplasmic RNA of 24 hr doxycycline-treated U2OS cells carrying an inducible inhibitor of cytoplasmic cap methyltransferase (RNMT). Libraries were prepared in house using the Lexogen QuantSeq REV kit. SRS4947280 SAMN11973392 DNRNMT_I_R4_3PTAG OTHER TRANSCRIPTOMIC Oligo-dT NextSeq 500 SRX6044156 DNRNMT_I_R5_3PTAG SRP201120 PRJNA547607 RNA-Seq was performed by Lexogen, GmbH, on cytoplasmic RNA of 24 hr doxycycline-treated U2OS cells carrying an inducible inhibitor of cytoplasmic cap methyltransferase (RNMT). Libraries were prepared in house using the Lexogen QuantSeq REV kit. SRS4947281 SAMN11973393 DNRNMT_I_R5_3PTAG OTHER TRANSCRIPTOMIC Oligo-dT NextSeq 500 SRX6044157 DNRNMT_C_R3_3PTAG SRP201120 PRJNA547607 RNA-Seq was performed by Lexogen, GmbH, on cytoplasmic RNA of untreated U2OS cells carrying an inducible inhibitor of cytoplasmic cap methyltransferase (RNMT). Libraries were prepared in house using the Lexogen QuantSeq REV kit. SRS4947282 SAMN11973386 DNRNMT_C_R3_3PTAG OTHER TRANSCRIPTOMIC Oligo-dT NextSeq 500 SRX6044158 DNRNMT_C_R4_3PTAG SRP201120 PRJNA547607 RNA-Seq was performed by Lexogen, GmbH, on cytoplasmic RNA of untreated U2OS cells carrying an inducible inhibitor of cytoplasmic cap methyltransferase (RNMT). Libraries were prepared in house using the Lexogen QuantSeq REV kit. SRS4947283 SAMN11973387 DNRNMT_C_R4_3PTAG OTHER TRANSCRIPTOMIC Oligo-dT NextSeq 500 SRX6044159 DNRNMT_C_R1_3PTAG SRP201120 PRJNA547607 RNA-Seq was performed by Lexogen, GmbH, on cytoplasmic RNA of untreated U2OS cells carrying an inducible inhibitor of cytoplasmic cap methyltransferase (RNMT). Libraries were prepared in house using the Lexogen QuantSeq REV kit. SRS4947284 SAMN11973384 DNRNMT_C_R1_3PTAG OTHER TRANSCRIPTOMIC Oligo-dT NextSeq 500 SRX6044160 DNRNMT_C_R2_3PTAG SRP201120 PRJNA547607 RNA-Seq was performed by Lexogen, GmbH, on cytoplasmic RNA of untreated U2OS cells carrying an inducible inhibitor of cytoplasmic cap methyltransferase (RNMT). Libraries were prepared in house using the Lexogen QuantSeq REV kit. SRS4947285 SAMN11973385 DNRNMT_C_R2_3PTAG OTHER TRANSCRIPTOMIC Oligo-dT NextSeq 500 SRX6044161 DNRNMT_I_R2_3PTAG SRP201120 PRJNA547607 RNA-Seq was performed by Lexogen, GmbH, on cytoplasmic RNA of 24 hr doxycycline-treated U2OS cells carrying an inducible inhibitor of cytoplasmic cap methyltransferase (RNMT). Libraries were prepared in house using the Lexogen QuantSeq REV kit. SRS4947286 SAMN11973390 DNRNMT_I_R2_3PTAG OTHER TRANSCRIPTOMIC Oligo-dT NextSeq 500 SRX6044162 DNRNMT_I_R3_3PTAG SRP201120 PRJNA547607 RNA-Seq was performed by Lexogen, GmbH, on cytoplasmic RNA of 24 hr doxycycline-treated U2OS cells carrying an inducible inhibitor of cytoplasmic cap methyltransferase (RNMT). Libraries were prepared in house using the Lexogen QuantSeq REV kit. SRS4947287 SAMN11973391 DNRNMT_I_R3_3PTAG OTHER TRANSCRIPTOMIC Oligo-dT NextSeq 500 SRX6044163 DNRNMT_C_R5_3PTAG SRP201120 PRJNA547607 RNA-Seq was performed by Lexogen, GmbH, on cytoplasmic RNA of untreated U2OS cells carrying an inducible inhibitor of cytoplasmic cap methyltransferase (RNMT). Libraries were prepared in house using the Lexogen QuantSeq REV kit. SRS4947288 SAMN11973388 DNRNMT_C_R5_3PTAG OTHER TRANSCRIPTOMIC Oligo-dT NextSeq 500 SRX6044164 DNRNMT_I_R1_3PTAG SRP201120 PRJNA547607 RNA-Seq was performed by Lexogen, GmbH, on cytoplasmic RNA of 24 hr doxycycline-treated U2OS cells carrying an inducible inhibitor of cytoplasmic cap methyltransferase (RNMT). Libraries were prepared in house using the Lexogen QuantSeq REV kit. SRS4947289 SAMN11973389 DNRNMT_I_R1_3PTAG OTHER TRANSCRIPTOMIC Oligo-dT NextSeq 500